Bafna Pharmaceuticals Limited (NSE:BAFNAPH)
72.00
-3.34 (-4.43%)
May 9, 2025, 1:39 PM IST
Bafna Pharmaceuticals Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
Cash & Equivalents | - | 13.96 | 78.09 | 1.73 | 18.04 | 84.8 | Upgrade
|
Cash & Short-Term Investments | 13.15 | 13.96 | 78.09 | 1.73 | 18.04 | 84.8 | Upgrade
|
Cash Growth | -83.28% | -82.12% | 4414.10% | -90.41% | -78.73% | 212.55% | Upgrade
|
Accounts Receivable | - | 453.95 | 411.49 | 147.8 | 95.6 | 60.35 | Upgrade
|
Other Receivables | - | - | - | - | 109.7 | 69.8 | Upgrade
|
Receivables | - | 454.77 | 412.03 | 148.76 | 205.3 | 130.15 | Upgrade
|
Inventory | - | 296.42 | 222.2 | 202.81 | 154.43 | 114.12 | Upgrade
|
Prepaid Expenses | - | 4.61 | 3.73 | - | 2.34 | 1.28 | Upgrade
|
Other Current Assets | - | 174.94 | 157.07 | 155.5 | 116.57 | 28.45 | Upgrade
|
Total Current Assets | - | 944.7 | 873.12 | 508.8 | 496.68 | 358.8 | Upgrade
|
Property, Plant & Equipment | - | 507.07 | 402.3 | 388.46 | 367.98 | 351.81 | Upgrade
|
Other Intangible Assets | - | 17.7 | 15 | - | - | - | Upgrade
|
Other Long-Term Assets | - | 7.35 | 5.42 | 4.19 | - | - | Upgrade
|
Total Assets | - | 1,477 | 1,296 | 901.45 | 864.66 | 710.61 | Upgrade
|
Accounts Payable | - | 354.22 | 284.61 | 124.05 | 106.92 | 125.41 | Upgrade
|
Accrued Expenses | - | 28.03 | 27.38 | 33.39 | 21.5 | 18.38 | Upgrade
|
Short-Term Debt | - | 100.11 | 119.09 | 45.92 | 100 | - | Upgrade
|
Current Portion of Long-Term Debt | - | 36.25 | 25.81 | 11.51 | 5 | - | Upgrade
|
Current Income Taxes Payable | - | 2.16 | 0.81 | 0.9 | - | 1 | Upgrade
|
Current Unearned Revenue | - | 0.99 | 0.99 | 0.66 | - | - | Upgrade
|
Other Current Liabilities | - | 19.07 | 6.07 | 3.71 | 9.67 | 26.18 | Upgrade
|
Total Current Liabilities | - | 540.83 | 464.76 | 220.13 | 243.09 | 170.98 | Upgrade
|
Long-Term Debt | - | 107.53 | 84.33 | 53.17 | 52.86 | 30.18 | Upgrade
|
Long-Term Unearned Revenue | - | 16.15 | 12.19 | 8.51 | - | - | Upgrade
|
Other Long-Term Liabilities | - | 3.92 | - | - | 1 | - | Upgrade
|
Total Liabilities | - | 668.43 | 561.29 | 281.81 | 296.95 | 201.16 | Upgrade
|
Common Stock | - | 236.56 | 236.56 | 236.56 | 236.56 | 23.66 | Upgrade
|
Additional Paid-In Capital | - | 753.77 | 753.77 | 753.77 | 753.77 | 413.11 | Upgrade
|
Retained Earnings | - | -451.76 | -525.6 | -640.51 | -692.43 | -750.69 | Upgrade
|
Comprehensive Income & Other | - | 269.81 | 269.81 | 269.81 | 269.81 | 823.37 | Upgrade
|
Total Common Equity | 827.51 | 808.39 | 734.55 | 619.64 | 567.71 | 509.46 | Upgrade
|
Shareholders' Equity | 827.51 | 808.39 | 734.55 | 619.64 | 567.71 | 509.46 | Upgrade
|
Total Liabilities & Equity | - | 1,477 | 1,296 | 901.45 | 864.66 | 710.61 | Upgrade
|
Total Debt | 188.23 | 243.89 | 229.24 | 110.59 | 157.86 | 30.18 | Upgrade
|
Net Cash (Debt) | -175.09 | -229.93 | -151.15 | -108.86 | -139.82 | 54.63 | Upgrade
|
Net Cash Per Share | -7.40 | -9.72 | -6.39 | -4.60 | -5.90 | 23.09 | Upgrade
|
Filing Date Shares Outstanding | 23.69 | 23.66 | 23.66 | 23.66 | 23.66 | 2.37 | Upgrade
|
Total Common Shares Outstanding | 23.69 | 23.66 | 23.66 | 23.66 | 23.66 | 2.37 | Upgrade
|
Working Capital | - | 403.87 | 408.35 | 288.67 | 253.59 | 187.82 | Upgrade
|
Book Value Per Share | 35.09 | 34.17 | 31.05 | 26.19 | 24.00 | 215.36 | Upgrade
|
Tangible Book Value | 809.81 | 790.69 | 719.55 | 619.64 | 567.71 | 509.46 | Upgrade
|
Tangible Book Value Per Share | 34.34 | 33.42 | 30.42 | 26.19 | 24.00 | 215.36 | Upgrade
|
Land | - | 1.93 | 1.93 | 1.93 | 1.93 | 1.93 | Upgrade
|
Buildings | - | 251.51 | 250.78 | 245.71 | 225.35 | 217.64 | Upgrade
|
Machinery | - | 741.42 | 693.86 | 631.75 | 568.38 | 521.33 | Upgrade
|
Construction In Progress | - | 104.96 | - | - | 8.31 | 2.12 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.